News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
204 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17909)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
2 (91)
3 (164)
4 (102)
7 (204)
8 (168)
9 (129)
10 (102)
11 (63)
14 (125)
15 (166)
16 (136)
17 (125)
18 (107)
21 (105)
22 (170)
23 (154)
24 (156)
25 (116)
28 (146)
29 (185)
30 (158)
31 (177)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
7
8
9
10
11
14
15
16
17
18
21
22
23
24
25
28
29
30
31
Deals
Cambrex Corporation Signs Agreement To Acquire ProSyntest AS
January 7, 2008
·
1 min read
Job Trends
MedImmune, Inc. Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas; Expands Staff to Continue Record of Investment Success
January 7, 2008
·
4 min read
Drug Development
Pharmasset, Inc. Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
January 7, 2008
·
7 min read
Business
Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer Inc. To Develop and Commercialize RNAi Hepatitis C Drug
January 7, 2008
·
3 min read
Previous
21 of 21